Clinical Trial Update: 18F-AV-1451 High Resolution Autopsy Study [Phase 1]

View source ↗

Summary

Phase 1 autopsy study update for the Alzheimer's disease imaging agent 18F-AV-1451 (flortaucipir) by Avid Radiopharmaceuticals; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• 18F-AV-1451 (flortaucipir) (flortaucipir)

Snippet

Sponsor: Avid Radiopharmaceuticals | Conditions: Alzheimer's Disease | Phase 1 | Status: COMPLETED | Results posted: 2025-06-10